Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP615050.RAyVngF0nnCvpVkBjEdFhNYqQ-ONVmhc0Nq4MX-BZxm7c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615050.RAyVngF0nnCvpVkBjEdFhNYqQ-ONVmhc0Nq4MX-BZxm7c130_assertion type Assertion NP615050.RAyVngF0nnCvpVkBjEdFhNYqQ-ONVmhc0Nq4MX-BZxm7c130_head.
- NP615050.RAyVngF0nnCvpVkBjEdFhNYqQ-ONVmhc0Nq4MX-BZxm7c130_assertion description "[In mice, the manipulation of cell cycle inhibitors such as CDKN1B (p27) and CDKN1A (p21) modifies the risk of developing atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615050.RAyVngF0nnCvpVkBjEdFhNYqQ-ONVmhc0Nq4MX-BZxm7c130_provenance.
- NP615050.RAyVngF0nnCvpVkBjEdFhNYqQ-ONVmhc0Nq4MX-BZxm7c130_assertion evidence source_evidence_literature NP615050.RAyVngF0nnCvpVkBjEdFhNYqQ-ONVmhc0Nq4MX-BZxm7c130_provenance.
- NP615050.RAyVngF0nnCvpVkBjEdFhNYqQ-ONVmhc0Nq4MX-BZxm7c130_assertion SIO_000772 17351341 NP615050.RAyVngF0nnCvpVkBjEdFhNYqQ-ONVmhc0Nq4MX-BZxm7c130_provenance.
- NP615050.RAyVngF0nnCvpVkBjEdFhNYqQ-ONVmhc0Nq4MX-BZxm7c130_assertion wasDerivedFrom befree-20140225 NP615050.RAyVngF0nnCvpVkBjEdFhNYqQ-ONVmhc0Nq4MX-BZxm7c130_provenance.
- NP615050.RAyVngF0nnCvpVkBjEdFhNYqQ-ONVmhc0Nq4MX-BZxm7c130_assertion wasGeneratedBy ECO_0000203 NP615050.RAyVngF0nnCvpVkBjEdFhNYqQ-ONVmhc0Nq4MX-BZxm7c130_provenance.